ArticleKidney international reports2025

Open-Label, Randomized, Controlled, Crossover Trial on the Effect of Dapagliflozin in Patients With ADPKD Receiving Tolvaptan.

Kiyotaka Uchiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.